[go: up one dir, main page]

ATE465747T1 - Rgd-angereicherte gelatineähnliche proteine zur verhinderung der blutplättchenaggregation - Google Patents

Rgd-angereicherte gelatineähnliche proteine zur verhinderung der blutplättchenaggregation

Info

Publication number
ATE465747T1
ATE465747T1 AT07111329T AT07111329T ATE465747T1 AT E465747 T1 ATE465747 T1 AT E465747T1 AT 07111329 T AT07111329 T AT 07111329T AT 07111329 T AT07111329 T AT 07111329T AT E465747 T1 ATE465747 T1 AT E465747T1
Authority
AT
Austria
Prior art keywords
rgd
enriched
gelatine
amino acids
gelatines
Prior art date
Application number
AT07111329T
Other languages
English (en)
Inventor
Jan Bastiaan Bouwstra
Es Andries Johannes Jozef Van
Yuzo Toda
Original Assignee
Fujifilm Mfg Europe Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujifilm Mfg Europe Bv filed Critical Fujifilm Mfg Europe Bv
Application granted granted Critical
Publication of ATE465747T1 publication Critical patent/ATE465747T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1658Proteins, e.g. albumin, gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/22Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/222Gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04Macromolecular materials
    • A61L31/043Proteins; Polypeptides; Degradation products thereof
    • A61L31/045Gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0068General culture methods using substrates
    • C12N5/0075General culture methods using substrates using microcarriers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00Supports or coatings for cell culture, characterised by material
    • C12N2533/30Synthetic polymers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00Supports or coatings for cell culture, characterised by material
    • C12N2533/50Proteins
    • C12N2533/54Collagen; Gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Surgery (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
AT07111329T 2003-03-28 2004-03-26 Rgd-angereicherte gelatineähnliche proteine zur verhinderung der blutplättchenaggregation ATE465747T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03075906 2003-03-28

Publications (1)

Publication Number Publication Date
ATE465747T1 true ATE465747T1 (de) 2010-05-15

Family

ID=33041011

Family Applications (4)

Application Number Title Priority Date Filing Date
AT07111329T ATE465747T1 (de) 2003-03-28 2004-03-26 Rgd-angereicherte gelatineähnliche proteine zur verhinderung der blutplättchenaggregation
AT07111303T ATE450548T1 (de) 2003-03-28 2004-03-26 Rgd-angereicherte gelatineähnliche proteine mit verstärkter zellbindung
AT04723872T ATE397626T1 (de) 2003-03-28 2004-03-26 Rgd-angereicherte gelatine-ähnliche proteine mit verstärkter zellbindung
AT07111368T ATE452649T1 (de) 2003-03-28 2004-03-26 Rgd-angereicherte, gelatine-ähnliche proteine zur verhinderung der zelladhäsion

Family Applications After (3)

Application Number Title Priority Date Filing Date
AT07111303T ATE450548T1 (de) 2003-03-28 2004-03-26 Rgd-angereicherte gelatineähnliche proteine mit verstärkter zellbindung
AT04723872T ATE397626T1 (de) 2003-03-28 2004-03-26 Rgd-angereicherte gelatine-ähnliche proteine mit verstärkter zellbindung
AT07111368T ATE452649T1 (de) 2003-03-28 2004-03-26 Rgd-angereicherte, gelatine-ähnliche proteine zur verhinderung der zelladhäsion

Country Status (6)

Country Link
US (8) US7517954B2 (de)
EP (7) EP1608681B1 (de)
JP (6) JP4834540B2 (de)
AT (4) ATE465747T1 (de)
DE (4) DE602004014263D1 (de)
WO (1) WO2004085473A2 (de)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1608681B1 (de) * 2003-03-28 2008-06-04 FUJIFILM Manufacturing Europe B.V. Rgd-angereicherte gelatine-ähnliche proteine mit verstärkter zellbindung
WO2006107188A1 (en) 2005-04-06 2006-10-12 Fujifilm Manufacturing Europe B.V. A non-porous film for culturing cells
JP5138580B2 (ja) * 2005-04-06 2013-02-06 フジフィルム マニュファクチャリング ユーロプ ビー.ブイ. 細胞培養用非孔質フィルム
EP2065056B1 (de) 2006-08-29 2016-09-28 FUJIFILM Corporation Hydrophile matrix enthaltend einer schwer wasserlöslichen verbindung und herstellungsverfahren dafür
EP1961414A1 (de) 2007-02-21 2008-08-27 FUJIFILM Manufacturing Europe B.V. Rekombinante Gelatine enthaltende Zusammensetzung mit gesteuerter Freisetzung
EP1961411A1 (de) 2007-02-21 2008-08-27 FUJIFILM Manufacturing Europe B.V. Zusammensetzung mit gesteuerter Freisetzung
US8349588B2 (en) * 2007-02-21 2013-01-08 Fujifilm Manufacturing Europe B.V. Recombinant XRGD-enriched gelatins having high stability
WO2008133196A1 (ja) * 2007-04-19 2008-11-06 Fujifilm Corporation 再生医療用材料
JP2008266179A (ja) 2007-04-19 2008-11-06 Fujifilm Corp 経肺用組成物
JP2009051773A (ja) * 2007-08-27 2009-03-12 Toyobo Co Ltd 細胞接着能を有するhsp70ファミリータンパク質
EP2221334B1 (de) 2007-11-28 2016-12-28 FUJIFILM Corporation Verfahren zur chemischen modifizierung von biopolymer und polypeptid
GB0724179D0 (en) * 2007-12-11 2008-01-23 Ct For Process Innovation The Fermentation process
WO2009075329A1 (ja) * 2007-12-11 2009-06-18 Fujifilm Corporation 分解性を調整したゼラチン組成物
US20110106243A1 (en) * 2008-07-04 2011-05-05 Elisabeth Marianna Wilhelmina Maria Van Dongen Coating Method for Medical Devices
JP2010053080A (ja) 2008-08-28 2010-03-11 Fujifilm Corp キトサンとコラーゲンを含む構造体
FR2936247B1 (fr) * 2008-09-24 2010-10-22 Ct Hospitalier Universitaire De Dijon Proteines recombinantes a activite hemostatique capables d'induire l'agregation plaquettaire.
US8263133B2 (en) * 2009-02-18 2012-09-11 The Regents Of The University Of California Multivalent clustering targeting strategy for drug carriers
JP5752033B2 (ja) * 2009-05-07 2015-07-22 富士フイルム株式会社 遺伝子組み換えゼラチンを含む血管新生誘導剤
JP5721140B2 (ja) * 2009-06-12 2015-05-20 富士フイルム株式会社 新生血管に対する標的化剤
WO2010147109A1 (ja) * 2009-06-15 2010-12-23 富士フイルム株式会社 遺伝子組み換えゼラチン及び塩基性線維芽細胞増殖因子を含む血管新生誘導剤
WO2011013792A1 (ja) 2009-07-30 2011-02-03 富士フイルム株式会社 遺伝子組み換えゼラチンを含む腎臓イメージング剤
EP2460540B1 (de) 2009-07-30 2017-02-15 FUJIFILM Corporation Auf die niere abgezieltes medikamentenverabreichungsmittel mit rekombinanter gelatine
CA2773062C (en) 2009-09-04 2017-04-18 Fujifilm Corporation A bone regeneration agent comprising gelatin
GB0921460D0 (en) 2009-12-08 2010-01-20 Fujifilm Mfg Europe Bv Anti-fibrotic hydrogel compositions
US8961929B2 (en) 2010-01-08 2015-02-24 Fujifilm Corporation Targeting agent for tumor site
KR101744040B1 (ko) 2010-03-01 2017-06-07 후지필름 가부시키가이샤 생체 친화성을 갖는 고분자 블록과 세포로 이루어지는 세포 구조체
KR101637431B1 (ko) 2010-03-02 2016-07-07 후지필름 가부시키가이샤 세포 지지체 및 골재생재
GB201008404D0 (en) 2010-05-20 2010-07-07 Fujifilm Mfg Europe Bv Hemostatic compositions
GB201014388D0 (en) 2010-08-31 2010-10-13 Fujifilm Mfg Europe Bv Biocompatible compositions for tissue augmentation
GB201018044D0 (en) 2010-10-26 2010-12-08 Fujifilm Mfg Europe Bv Non-natural gelatin-like proteins with enhanced functionality
JP5847418B2 (ja) 2011-03-30 2016-01-20 富士フイルム株式会社 細胞接着性タンパク質
US20120263681A1 (en) 2011-04-12 2012-10-18 Fujifilm Corporation Composition comprising cell and biocompatible polymer
JP5876787B2 (ja) 2011-08-31 2016-03-02 富士フイルム株式会社 細胞移植用細胞構造体および細胞移植用細胞集合体
JP5808631B2 (ja) 2011-09-29 2015-11-10 富士フイルム株式会社 血管新生用足場、及び再生医療用の血管の製造方法
GB201119173D0 (en) 2011-11-07 2011-12-21 Fujifilm Mfg Europe Bv Porous tissue scaffolds
GB201119182D0 (en) 2011-11-07 2011-12-21 Fujifilm Mfg Europe Bv Porous tissue scaffolds
KR101638834B1 (ko) 2012-03-12 2016-07-12 후지필름 가부시키가이샤 조직 수복재의 제조 방법
JP5992529B2 (ja) 2012-09-26 2016-09-14 富士フイルム株式会社 ポリペプチド、足場組成物、軟骨組織修復用組成物、軟骨細胞培養用組成物及びグリコサミノグリカン産生促進用組成物
EP2949347B1 (de) 2013-01-25 2021-06-16 FUJIFILM Corporation Künstliche dermis für transplantation und verfahren zur herstellung davon
JP6130903B2 (ja) 2013-02-27 2017-05-17 富士フイルム株式会社 細胞移植用細胞構造体、生体親和性高分子ブロック及びそれらの製造方法
WO2014141877A1 (ja) 2013-03-12 2014-09-18 富士フイルム株式会社 組織修復材
EP3050580B1 (de) 2013-09-25 2020-02-19 FUJIFILM Corporation Verfahren zur herstellung eines biokompatiblen makromolekularen porösen körpers, biokompatibler makromolekularer poröser körper, biokompatibler makromolekularer block und zellstruktur
EP3156081B1 (de) 2014-06-16 2025-04-02 FUJIFILM Corporation Zellstruktur zur verwendung bei der behandlung von gehirnverletzungen, verfahren zur herstellung davon und therapeutisches mittel gegen hirnverletzungen
EP3088010B1 (de) 2015-04-28 2022-12-21 DiCosmo, Frank Bioaktive kollagenbiomaterialien und verfahren zur herstellung
WO2016208673A1 (ja) 2015-06-25 2016-12-29 学校法人早稲田大学 コラーゲン様構造を有する重合ペプチド及びゲル
EP3348384B1 (de) 2015-09-11 2023-06-28 FUJIFILM Corporation Verfahren zur herstellung einer gelatinestruktur und system zur herstellung einer gelatinestruktur
WO2017170342A1 (ja) 2016-03-29 2017-10-05 富士フイルム株式会社 細胞シート包埋剤、細胞シート含有組成物およびキット
WO2017183710A1 (ja) 2016-04-21 2017-10-26 フジフィルム・マニュファクチュアリング・ヨーロッパ・ベスローテン・フエンノートシャップ 多孔質ゼラチンシートの製造方法、多孔質ゼラチンシートおよびその利用
EP3466905B1 (de) 2016-05-30 2021-12-15 FUJIFILM Corporation Verfahren zur herstellung eines calziumphosphatformartikel, calciumphosphatformartikel und material zur transplantation
CN109311224B (zh) 2016-06-08 2020-12-29 富士胶片株式会社 明胶成型体的制造方法及明胶成型体
JP6865265B2 (ja) 2017-03-02 2021-04-28 富士フイルム株式会社 細胞塊または細胞構造体の包埋剤、細胞塊または細胞構造体含有組成物およびキット
JP6854879B2 (ja) 2017-03-16 2021-04-07 富士フイルム株式会社 巨核球と血小板とを分離する方法および巨核球と血小板とを分離するための器具
JP6964313B2 (ja) 2017-03-17 2021-11-10 富士フイルム株式会社 細胞構造体の製造方法
EP3623466A4 (de) 2017-05-12 2020-08-12 FUJIFILM Corporation Verfahren zur herstellung mesenchymaler stammzellen und anwendung davon
CN116270739A (zh) 2017-06-30 2023-06-23 富士胶片株式会社 细胞结构体在制造溶酶体贮积病处置剂中的用途
WO2019044990A1 (ja) 2017-08-30 2019-03-07 富士フイルム株式会社 細胞移植用デバイスおよびその製造方法
EP3677289A4 (de) 2017-08-30 2020-08-26 FUJIFILM Corporation Angiogenes mittel und herstellungsverfahren dafür
KR102476632B1 (ko) * 2017-11-06 2022-12-09 후지필름 가부시키가이샤 진주 양식용 재료 및 코팅용 조성물
JP7078939B2 (ja) 2017-11-10 2022-06-01 富士フイルム株式会社 間葉系幹細胞からインスリン産生細胞を製造する方法、インスリン産生細胞、細胞構造体および医薬組成物
JP7036839B2 (ja) 2018-01-30 2022-03-15 富士フイルム株式会社 フィブリン組成物、再生医療用基材、フィブリン組成物の製造方法およびキット
WO2020050205A1 (ja) 2018-09-03 2020-03-12 富士フイルム株式会社 ゲル形成キット、ゲルおよびゲルの製造方法
KR102141537B1 (ko) * 2019-03-11 2020-08-06 재단법인대구경북과학기술원 신경 줄기세포의 구형배양 방법
WO2021020268A1 (ja) 2019-07-26 2021-02-04 富士フイルム株式会社 生体移植材料
EP4019025A4 (de) 2019-08-23 2022-11-30 FUJIFILM Corporation Zusammensetzung mit mikrokapsel und zellstruktur
EP4159916A4 (de) 2020-05-25 2023-09-06 FUJIFILM Corporation Zusammensetzung, blattförmiger formkörper, kunstleder und verfahren zur herstellung eines blattförmigen formkörpers
JPWO2022202632A1 (de) 2021-03-24 2022-09-29
EP4299482A4 (de) 2021-03-26 2024-12-25 FUJIFILM Corporation Pulverversorgungsvorrichtung
CN117043535A (zh) 2021-03-26 2023-11-10 富士胶片株式会社 冷冻干燥用容器
WO2022210204A1 (ja) 2021-03-31 2022-10-06 富士フイルム株式会社 粉砕方法、高分子ブロック製造方法及び粉砕装置
WO2023013596A1 (ja) 2021-08-02 2023-02-09 株式会社Rainbow 幹細胞を非凍結で保存または輸送するための方法
CN113788891B (zh) * 2021-09-15 2023-10-31 山西锦波生物医药股份有限公司 一种重组i型人源化胶原蛋白c1l4t及其制备方法和用途
WO2023053710A1 (ja) 2021-09-30 2023-04-06 富士フイルム株式会社 組織修復材キット及び組織修復方法
JPWO2023188492A1 (de) 2022-03-30 2023-10-05

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4988621A (en) * 1985-05-24 1991-01-29 La Jolla Cancer Research Foundation Peptides in cell detachment and aggregation
US5514581A (en) 1986-11-04 1996-05-07 Protein Polymer Technologies, Inc. Functional recombinantly prepared synthetic protein polymer
CA1324954C (en) * 1988-03-10 1993-12-07 Erkki I. Ruoslahti Inhibition of cell migration with synthetic peptides
US4994388A (en) 1988-04-15 1991-02-19 Solohill Engineering, Inc. Collagen-coated polystyrene microcarrier beads
JPH04221400A (ja) * 1990-10-26 1992-08-11 Fuji Photo Film Co Ltd ゼラチン誘導体およびその用途
US5179082A (en) * 1990-11-13 1993-01-12 Merck & Co., Inc. Method for blocking platelet adhesion to collagen
AU3064892A (en) * 1991-11-07 1993-06-07 University Of Southern California Compositions and methods for preventing adhesion formation
US5512474A (en) 1992-05-29 1996-04-30 Bsi Corporation Cell culture support containing a cell adhesion factor and a positively-charged molecule
JPH06192291A (ja) 1992-09-07 1994-07-12 Nippon Steel Corp 新規ペプチドとそれを用いた血小板凝集抑制剤及び血液凝固抑制剤
DE69427363T2 (de) * 1993-09-30 2002-03-14 Nippon Steel Corp., Tokio/Tokyo Plättchenaggregationsinhibierende peptide
IL114140A (en) * 1995-06-14 2000-06-01 Hadasit Med Res Service Anti-metastatic and anti-angiogenetic pharmaceutical compositions
EP0950098B1 (de) * 1996-10-29 2008-09-03 Commonwealth Scientific And Industrial Research Organisation Stabile expression von tripelhelikalen proteinen
US5972332A (en) 1997-04-16 1999-10-26 The Regents Of The University Of Michigan Wound treatment with keratinocytes on a solid support enclosed in a porous material
NL1007908C2 (nl) 1997-12-24 1999-06-25 Fuji Photo Film Bv Zilverhalide-emulsies met recombinant collageen die geschikt zijn voor fotografische toediening alsmede de bereiding daarvan.
EP1014176B1 (de) 1998-12-23 2009-04-29 FUJIFILM Manufacturing Europe B.V. Silberhalogenidemulsionen, die rekombinante gelatineartige Proteine enthalten
HK1046016B (en) * 1999-11-12 2009-02-27 Fibrogen, Inc. Recombinant gelatin in vaccines
US6992172B1 (en) * 1999-11-12 2006-01-31 Fibrogen, Inc. Recombinant gelatins
CA2401385C (en) * 2000-02-28 2011-05-17 Gel-Del Technologies, Inc. Protein matrix materials, devices and methods of making and using thereof
AUPR311601A0 (en) 2001-02-15 2001-03-08 Adp Pharmaceutical Pty Limited Matrix gene expression in chondrogenesis
EP1238675A1 (de) 2001-03-06 2002-09-11 Fuji Photo Film B.V. Rekombinante gelatineartige Proteine zur Verwendung als Plasmaexpander
EP1608681B1 (de) * 2003-03-28 2008-06-04 FUJIFILM Manufacturing Europe B.V. Rgd-angereicherte gelatine-ähnliche proteine mit verstärkter zellbindung
WO2013004646A1 (en) 2011-07-05 2013-01-10 Unilever N.V. Laminate for packaging

Also Published As

Publication number Publication date
JP2007297402A (ja) 2007-11-15
JP4834618B2 (ja) 2011-12-14
EP1845107A3 (de) 2008-01-23
JP2007528699A (ja) 2007-10-18
EP1608681A2 (de) 2005-12-28
US20060241032A1 (en) 2006-10-26
WO2004085473A2 (en) 2004-10-07
EP1875924A2 (de) 2008-01-09
EP1875924A3 (de) 2008-02-13
US20080114078A1 (en) 2008-05-15
US7671016B2 (en) 2010-03-02
WO2004085473A3 (en) 2005-04-21
US7645737B2 (en) 2010-01-12
JP2007308507A (ja) 2007-11-29
US20100222264A1 (en) 2010-09-02
US20100048477A1 (en) 2010-02-25
US7579314B2 (en) 2009-08-25
US7517954B2 (en) 2009-04-14
US20080167446A1 (en) 2008-07-10
EP2112163A2 (de) 2009-10-28
US20090182063A1 (en) 2009-07-16
ATE450548T1 (de) 2009-12-15
DE602004014263D1 (de) 2008-07-17
ATE397626T1 (de) 2008-06-15
US8138139B2 (en) 2012-03-20
EP1918301A1 (de) 2008-05-07
JP2007297401A (ja) 2007-11-15
EP1862476A3 (de) 2008-02-13
EP1862476B1 (de) 2009-12-23
EP1845107A2 (de) 2007-10-17
DE602004024463D1 (de) 2010-01-14
US20080113910A1 (en) 2008-05-15
JP2007297403A (ja) 2007-11-15
ATE452649T1 (de) 2010-01-15
EP1894945A2 (de) 2008-03-05
EP2112163A3 (de) 2010-01-20
DE602004024834D1 (de) 2010-02-04
EP1845107B1 (de) 2019-05-29
US20080274957A1 (en) 2008-11-06
JP4834540B2 (ja) 2011-12-14
EP1894945A3 (de) 2008-10-29
EP1608681B1 (de) 2008-06-04
JP2007314545A (ja) 2007-12-06
EP1862476A2 (de) 2007-12-05
US7560427B2 (en) 2009-07-14
EP1894945B1 (de) 2009-12-02
DE602004026944D1 (de) 2010-06-10
EP1875924B1 (de) 2010-04-28
US7598347B2 (en) 2009-10-06
US8080515B2 (en) 2011-12-20

Similar Documents

Publication Publication Date Title
ATE465747T1 (de) Rgd-angereicherte gelatineähnliche proteine zur verhinderung der blutplättchenaggregation
Davari et al. Protein-based hydrogels: promising materials for tissue engineering
Schloss et al. Protein-based hydrogels for tissue engineering
Barsotti et al. Fibrin as a scaffold for cardiac tissue engineering
Isenberg et al. Small-diameter artificial arteries engineered in vitro
Yamada et al. Potency of fish collagen as a scaffold for regenerative medicine
EP0366777B1 (de) Erregung der chemotaxe durch chemotaktische peptide
Bermueller et al. Marine collagen scaffolds for nasal cartilage repair: prevention of nasal septal perforations in a new orthotopic rat model using tissue engineering techniques
US20160194378A1 (en) Peptides and uses thereof
US11179494B2 (en) Collagenous tissue repair device
US12280176B2 (en) Methods and compositions for matrix preparation
WO2004076631A3 (en) Biologically active native biomatrix composition
ATE430165T1 (de) Peptide mit integrinbindungsmotiv und behandlungsmethoden für muskelkrankheiten
Zhao et al. Understanding cell homing-based tissue regeneration from the perspective of materials
CN101094697B (zh) 用寻靶因子进行工程改造
Zhai et al. Comprehensive Review on Application Progress of Marine Collagen Cross-Linking Modification in Bone Repairs
EP2640877A2 (de) Kollagenstrukturen und herstellungsverfahren dafür
Wongin et al. Effect of cell sheet manipulation techniques on the expression of collagen type II and stress fiber formation in human chondrocyte sheets
Arslan et al. Sophisticated biocomposite scaffolds from renewable biomaterials for bone tissue engineering
Yang et al. Protein-Based Biomaterials for Tissue Engineering and Regenerative Medicine
ATE395101T1 (de) Pharmazeutische zusammensetzung, enthaltend proteine und/oder polypeptide sowie kolloidpartikel
Hayashi Fish Collagen: Characteristics and Application
Hanson et al. Mechanical characterization and in vitro chondrogenic evaluation of chemically crosslinked elastin-like polypeptide hydrogels
Bharti et al. Biomaterials and Scaffolds in Stem Cell Therapy
Grassl et al. Fibrillar fibrin gels

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties